Next Article in Journal
The Effects of L-Theanine Supplementation on Quality of Sleep: A Systematic Review
Previous Article in Journal
Changes in Eating Habits and Contributing Factors during the COVID-19 Pandemic among Medical Students in the Slovak Republic
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Identifying a Complex Carbohydrate Mixture in Context of a High-Protein Diet That Is Able to Steer Microbial Fermentation to Improve Metabolic Health: The DISTAL Study †

1
Department of Human Biology, School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
2
Department of Human Biology, Maastricht University, 6211 LK Maastricht, The Netherlands
*
Author to whom correspondence should be addressed.
Presented at the 14th European Nutrition Conference FENS 2023, Belgrade, Serbia, 14–17 November 2023.
Proceedings 2023, 91(1), 25; https://doi.org/10.3390/proceedings2023091025
Published: 14 November 2023
(This article belongs to the Proceedings of The 14th European Nutrition Conference FENS 2023)

Abstract

:
Background: The microbial metabolites short-chain fatty acids (SCFAs) are proposed to largely contribute to improvements in metabolic health associated with dietary fiber (saccharolytic) fermentation. Nevertheless, towards the distal colon, fermentable carbohydrates become depleted, and gut bacteria switches towards protein (proteolytic) fermentation. This yields a diversity of metabolites like branched-chain fatty acids (BCFAs), often considered detrimental to metabolic health. We previously demonstrated that acute SCFA administration to the distal, but not the proximal colon, led to beneficial alterations in human substrate and energy metabolism. Hence, we hypothesize that a switch from proteolytic to saccharolytic fermentation in the distal colon has the most pronounced metabolic health effects and aimed to identify a complex carbohydrate mixture capable of inducing such a microbial substrate switch. Methods: The TIM-2 model, an in vitro computer-controlled dynamic model, was used to mimic colonic fermentation, simulating amongst others body temperature, luminal pH, microbial metabolite absorption, and peristalsis. TIM-2 was inoculated with standardized pooled microbiota from individuals with overweight/obesity and disturbed glucose homeostasis. After an overnight adaptation period, pre-digested proteins were added to the model to create a high protein background. Subsequently, either separately or in combination, potato fiber, native inulin from chicory, pectin from sugar beet, or no fibers (protein control) were administered. Samples of the lumen and dialysate were taken at various time points and assessed for proximal (0–8 h) and distal (8–24 h) SCFA and BCFA levels. Results: Of all the tested combinations, combining potato fiber and pectin resulted in the highest distal SCFA production (26.3 vs 6.4 mmol) and SCFA:BCFA ratio (13.3 vs 2.2) compared to the protein control. Discussion: The combination of potato fiber and pectin was best able to increase distal SCFA production in pooled microbiota of individuals who were overweight/obese. To assess whether these results translate to improvements in metabolic health, we are currently conducting a 12-week double-blind placebo-controlled randomized study. 44 individuals who are overweight/obese and have a disturbed glucose homeostasis are randomized to supplementation with a potato fiber/pectin mixture or placebo (maltodextrin) while consuming an eucaloric high protein diet (25 E% protein). The primary outcome will be the change in peripheral insulin sensitivity.

Author Contributions

Conceptualization, T.v.D., E.B. and K.V. Writing—original draft preparation, T.v.D. Writing—review and editing, E.B., K.V. and C.v.K. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by NWO the Netherlands Organization of Scientific Research (the ENW-public private partnership fund) and the Carbohydrate Competence Center (CCC). Industrial partners within this partnership included: Avebe, Sensus, Nuscience, and Agrifirm.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki, and the human intervention study was approved by the Institutional Review Board (or Ethics Committee) of METC (METC22-011, NL80459.068.22, 25-05-2023). ClinicalTrials.gov Identifier: NCT05354245.

Informed Consent Statement

Not applicable (for data presented here).

Data Availability Statement

The datasets presented in the abstract are not readily available as current investigations are still ongoing but will be made available upon reasonable request. Requests to access the dataset should be direct to [email protected].

Conflicts of Interest

The authors declare no conflict of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

van Deuren, T.; van Kalkeren, C.; Venema, K.; Blaak, E. Identifying a Complex Carbohydrate Mixture in Context of a High-Protein Diet That Is Able to Steer Microbial Fermentation to Improve Metabolic Health: The DISTAL Study. Proceedings 2023, 91, 25. https://doi.org/10.3390/proceedings2023091025

AMA Style

van Deuren T, van Kalkeren C, Venema K, Blaak E. Identifying a Complex Carbohydrate Mixture in Context of a High-Protein Diet That Is Able to Steer Microbial Fermentation to Improve Metabolic Health: The DISTAL Study. Proceedings. 2023; 91(1):25. https://doi.org/10.3390/proceedings2023091025

Chicago/Turabian Style

van Deuren, Thirza, Colin van Kalkeren, Koen Venema, and Ellen Blaak. 2023. "Identifying a Complex Carbohydrate Mixture in Context of a High-Protein Diet That Is Able to Steer Microbial Fermentation to Improve Metabolic Health: The DISTAL Study" Proceedings 91, no. 1: 25. https://doi.org/10.3390/proceedings2023091025

Article Metrics

Back to TopTop